Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13338843 | 0.84 | HRH4 (0.33) | LMNATAAR1CYP2D6CYP2C19ADRA2A | |
| SCHEMBL13338487 | 0.84 | KDM4E (0.38) | SIGMAR1LMNACYP2A6ADRA2AADRA2B | |
| SCHEMBL13338642 | 0.82 | TAAR1 (0.35) | LMNATAAR1CYP2D6CYP2C19CYP3A4 | |
| SCHEMBL13338369 | 0.81 | SIGMAR1 (0.52) | SIGMAR1CYP2A6CYP2D6CYP2C19CYP3A4 | |
| SCHEMBL13338827 | 0.80 | CYP2A6 (0.42) | LMNATAAR1CYP2A6CYP2D6CYP2C19 | |
| SCHEMBL13338831 | 0.80 | PABPC1 (0.40) | LMNATAAR1CYP2D6CYP2C19CYP3A4 | |
| SCHEMBL13338372 | 0.79 | CYP2D6 (0.47) | LMNATAAR1CYP2D6CYP2C19ADRA2A | |
| SCHEMBL13367399 | 0.79 | SIGMAR1 (0.47) | SIGMAR1CYP2A6CYP2D6CYP2C19ADRA2A | |
| SCHEMBL13338488 | 0.78 | CYP2A6 (0.43) | SIGMAR1LMNACYP2A6CYP2D6CYP2C19 | |
| SCHEMBL13338492 | 0.78 | SLC6A2 (0.43) | SIGMAR1LMNAADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | SIGMAR1 699/4885LMNA 4085/4885TAAR1 1913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.